SCHEMBL6981593

SCHEMBL6981593

CCCCC(=O)N(Cc1ccccc1)c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C#N)cc1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LTB4R2 Q9NPC1 10/20 0.52
NR3C1 P04150 2/20 0.43
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 2/20 0.40
HPGD P15428 2/20 0.40
KMT2A Q03164 2/20 0.40
TP53 P04637 1/20 0.40
AVPR2 P30518 1/20 0.40
OXTR P30559 1/20 0.40
AVPR1A P37288 1/20 0.40
USP2 O75604 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6980751 0.90 NOTUM (0.44) LTB4R2NR3C1ALDH1A1MEN1HPGD
SCHEMBL6986006 0.89 NR3C1 (0.46) NR3C1ALDH1A1MEN1HPGDKMT2A
SCHEMBL7962885 0.87 NR3C1 (0.41) LTB4R2NR3C1ALDH1A1MEN1HPGD
Hydrochloric Acid SCHEMBL6985844 0.86 LTB4R2 (0.45) LTB4R2NR3C1AVPR2OXTRAVPR1A
SCHEMBL6985998 0.86 NR3C1 (0.47) NR3C1ALDH1A1MEN1HPGDKMT2A
SCHEMBL7962882 0.85 NR3C1 (0.39) LTB4R2NR3C1ALDH1A1MEN1HPGD
SCHEMBL6981595 0.85 LTB4R2 (0.46) LTB4R2ALDH1A1MEN1HPGDKMT2A
SCHEMBL6980094 0.84 KDM1A (0.42) LTB4R2NR3C1ALDH1A1MEN1HPGD
SCHEMBL6987628 0.83 NR3C1 (0.48) NR3C1ALDH1A1MEN1HPGDKMT2A
SCHEMBL6982684 0.83 KDM1A (0.43) NR3C1ALDH1A1MEN1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed